
Gerard Siest
ESPT President
Universite de Lorraine
France
Biography
-Professor of Molecular Biology and Biochemical Pharmacology at the Faculty of Pharmaceutical Sciences, University of Lorraine (Emeritus) -Director of the postgraduate course in Biochemical Pharmacology (1977-2003) -Founder and member of Directing Group of DU “Thérapie Personnalisée – Pharmacogénétique†(2009-2011) -Member of the Board of the International Society of Pharmacogenomics (ISP) -Editor in Chief of Drug Metabolism and Drug Interactions -Past Editor in Chief of Clinical Chemistry and Laboratory Medicine (1997-2009) -Member of the Editorial Boards of : -Fundamental and Clinical Pharmacology -Pharmacogenomics -Personalized Medicine -Pharmacogenomics and Personalized Medicine: Advance and Applications -Current Pharmacogenomics and Personalized Medicine -International Journal of Clinical Pharmacology and Toxicology (IJCPT) -President of the European Society of Pharmacogenomics and Theranostics (ESPT) -Past-President of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) (1990-1996) -Chairman of the Expert Panel of the International Federation of Clinical Chemistry "Drug Effect in Clinical Chemistry"(1978-1986) -Member of the Council of the International Society for the Study of Xenobiotics (ISSX) (1982-1983) -Member of the Membership Affairs Committee of ISSX (1988-2002) -Chairman of the European Society of Biochemical Pharmacology (1984-1986) -Doctor Honoris Causa from Laval and Krakow Universities; member of the Royal Academy of Medicine in Belgium; and recipient of 27 awards from 16 different countries -Organizer of the Pont-à -Mousson Biologie Prospective Meetings (1970-2006) and the Santorini Biologie Prospective Colloquia (2002, 2004, 2006, 2008, 2010, 2012, 2014) -Author of more than 600 publications in peer reviewed journals
Research Interest
- Apo E isoforms and function - Pharmacogenomics and drug metabolizing enzymes and transporters - Cardiovascular biomarkers and systems biology for personalized health for cardiovascular drugs (Clopidogrel) - Proteomic biomarkers and reference values